(Q39116780)

9 September 2017

title

Anti-cancer activity of DHA on gastric cancer--an in vitro and in vivo study (English)

1 reference

9 September 2017

Haijun Sun

1

1 reference

9 September 2017

Xianzhi Meng

2

1 reference

9 September 2017

Jihua Han

3

1 reference

9 September 2017

Zhe Zhang

4

1 reference

9 September 2017

Bing Wang

5

1 reference

9 September 2017

Xuedong Bai

6

1 reference

9 September 2017

Xin Zhang

7

1 reference

9 September 2017

publication date

2 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

34

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

3791-3800

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0963-0

9 September 2017

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Multidisciplinary management of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Biological activity of dihydroartemisinin in canine osteosarcoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Role of microRNA in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Ionizing radiation potentiates dihydroartemisinin-induced apoptosis of A549 cells via a caspase-8-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Drugs targeting Bcl-2 family members as an emerging strategy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0963-0

Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23907579

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-0963-0

1 reference

9 September 2017

1 reference